CalciMedica Statistics

Total Valuation

CalciMedica has a market cap or net worth of $31.68 million. The enterprise value is $17.08 million.

Market Cap	31.68M
Enterprise Value	17.08M

Important Dates

The next estimated earnings date is Thursday, March 27, 2025, before market open.

Earnings Date	Mar 27, 2025
Ex-Dividend Date	n/a

Share Statistics

CalciMedica has 13.48 million shares outstanding. The number of shares has increased by 207.27% in one year.

Current Share Class	13.48M
Shares Outstanding	13.48M
Shares Change (YoY)	+207.27%
Shares Change (QoQ)	+0.05%
Owned by Insiders (%)	11.56%
Owned by Institutions (%)	16.44%
Float	6.69M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.80
P/TBV Ratio	3.51
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.15

Current Ratio	4.15
Quick Ratio	3.86
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -128.26% and return on invested capital (ROIC) is -131.85%.

Return on Equity (ROE)	-128.26%
Return on Assets (ROA)	-87.15%
Return on Invested Capital (ROIC)	-131.85%
Return on Capital Employed (ROCE)	-179.81%
Revenue Per Employee	n/a
Profits Per Employee	-$1.13M
Employee Count	12
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -46.10% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-46.10%
50-Day Moving Average	2.82
200-Day Moving Average	4.00
Relative Strength Index (RSI)	35.05
Average Volume (20 Days)	32,015

Short Selling Information

The latest short interest is 69,061, so 0.51% of the outstanding shares have been sold short.

Short Interest	69,061
Short Previous Month	71,960
Short % of Shares Out	0.51%
Short % of Float	1.03%
Short Ratio (days to cover)	2.51

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-22.35M
Pretax Income	-14.94M
Net Income	-13.59M
EBITDA	-22.29M
EBIT	-22.35M
Earnings Per Share (EPS)	-$1.44

Full Income Statement

Balance Sheet

Cash & Cash Equivalents	14.60M
Total Debt	n/a
Net Cash	14.60M
Net Cash Per Share	$1.08
Equity (Book Value)	9.03M
Book Value Per Share	0.84
Working Capital	11.90M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$19.79 million and capital expenditures -$6,000, giving a free cash flow of -$19.79 million.

Operating Cash Flow	-19.79M
Capital Expenditures	-6,000
Free Cash Flow	-19.79M
FCF Per Share	-$1.47

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CalciMedica does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-207.27%
Shareholder Yield	-207.27%
Earnings Yield	-42.89%
FCF Yield	-62.47%

Analyst Forecast

The average price target for CalciMedica is $17.25, which is 674.47% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$17.25
Price Target Difference	674.47%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1